← Leaderboards
Jane E Salmon
Hospital For Special Surgery
$19,797,001
Attributed
$21,659,477
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,659,477 · 11
By mechanism
R01$16,575,686 · 3
T32$2,944,814 · 2
R21$1,850,527 · 3
R13$148,450 · 1
R55$100,000 · 1
U13$40,000 · 1
Top collaborators
- Alessandra B Pernis9 shared
- D.Ware Branch5 shared
- Mimi Y. Kim2 shared
Most similar at Hospital For Special Surgery
Same institution · by research overlap
- Keith B Elkon$11,294,503
Others in their field
Top investigators on “Antiphospholipid Syndrome”
- Mortimer Poncz · University Of Pennsylvania$9,194,517
- Thomas L Ortel · Duke University$8,689,700
- Judith A James · Oklahoma Medical Research Foundation$5,282,619
- Robert C Flaumenhaft · Beth Israel Deaconess Medical Center$5,020,260
- Eugene W. St Clair · Duke University$5,003,883
- Michelle A Petri · Johns Hopkins University$4,340,066
Research focus
Antiphospholipid SyndromeWomanPreventFetalPregnancyAntiphospholipid AntibodiesComplementPregnancy OutcomeInflammatoryTissuesSystemic Lupus ErythematosusInflammationPlacental InsufficiencyMediator Of Activation ProteinMorbidity - Disease RatePregnancy LossPre-EclampsiaInjuryPregnancy ComplicationsComplement ActivationHeparinFetal Growth RetardationMediatingLead
Grant awards (52)
HSS Research Institute Rheumatology Training$269,182
T32 · FY2025 · AR · contact PI
HSS Research Institute Rheumatology Training$241,317
T32 · FY2024 · AR · contact PI
HSS Research Institute Rheumatology Training$363,203
T32 · FY2023 · AR · contact PI
HSS Research Institute Rheumatology Training$308,469
T32 · FY2022 · AR · contact PI
TNF-alpha Blockade with Certolizumab to Prevent Pregnancy Complications in High-Risk Patients with APS$174,810
R21 · FY2022 · AR · contact PI
Hospital for Special Surgery Research Institute Rheumatology Training$256,739
T32 · FY2021 · AR · contact PI
Adverse pregnancy outcomes in women with systemic lupus erythematosus: improving and validating risk prediction$185,269
R21 · FY2021 · AR · contact PI
Adverse pregnancy outcomes in women with systemic lupus erythematosus: improving and validating risk prediction$249,418
R21 · FY2020 · AR · contact PI
Hospital for Special Surgery Research Institute Rheumatology Training$209,435
T32 · FY2020 · AR · contact PI
TNF-alpha Blockade with Certolizumab to Prevent Pregnancy Complications in High-Risk Patients with APS$196,279
R21 · FY2020 · AR · contact PI
Hospital for Special Surgery Research Institute Rheumatology Training$174,039
T32 · FY2019 · AR · contact PI
Hospital for Special Surgery Research Institute Rheumatology Training$239,645
T32 · FY2018 · AR · contact PI
TNF-alpha Blockade with Certolizumab to Prevent Pregnancy Complications in High-Risk Patients with APS$143,980
R21 · FY2018 · AR · contact PI
Hospital for Special Surgery Research Institute Rheumatology Training$236,888
T32 · FY2017 · AR · contact PI
TNF-alpha Blockade with Certolizumab to Prevent Pregnancy Complications in High-Risk Patients with APS$224,372
R21 · FY2017 · AR · contact PI
TNF-alpha Blockade with Certolizumab to Prevent Pregnancy Complications in High-Risk Patients with APS$251,908
R21 · FY2016 · AR · contact PI
Inhibition of ROCK to reverse T cell dysfunction in SLE$187,566
R21 · FY2013 · AR · contact PI
Predictors of Pregnancy Outcome In SLE and APS$1,213,915
R01 · FY2012 · AR · contact PI
Inhibition of ROCK to reverse T cell dysfunction in SLE$236,925
R21 · FY2012 · AR · contact PI
Predictors of Pregnancy Outcome In SLE and APS$1,244,577
R01 · FY2011 · AR · contact PI
Predictors of Pregnancy Outcome In SLE and APS$1,260,461
R01 · FY2010 · AR · contact PI
Mechanism of aPL antibody-induced Pregnancy loss$362,696
R01 · FY2010 · AR · contact PI
Predictors of Pregnancy Outcome In SLE and APS$1,271,869
R01 · FY2009 · AR · contact PI
Predictors of Pregnancy Outcome In SLE and APS$469,996
R01 · FY2009 · AR · contact PI
Mechanism of aPL antibody-induced pregnancy loss$366,359
R01 · FY2009 · AR · contact PI
Predictors of Pregnancy Outcome In SLE and APS$1,404,726
R01 · FY2008 · AR · contact PI
Mechanisms of aPL antibody-induced pregnancy loss$366,359
R01 · FY2008 · AR · contact PI
Complement as a Mediator of Recurrent Miscarriages$330,209
R01 · FY2008 · AI · contact PI
Predictors of Pregnancy Outcome in SLE and APS$1,089,221
R01 · FY2007 · AR · contact PI
Mechanisms of aPL antibody-induced pregnancy loss$372,767
R01 · FY2007 · AR · contact PI
Complement as a Mediator of Recurrent Miscarriages$336,604
R01 · FY2007 · AI · contact PI
Predictors of Pregnancy Outcome in SLE and APS$1,096,742
R01 · FY2006 · AR · contact PI
Complement as a Mediator of Recurrent Miscarriages$346,658
R01 · FY2006 · AI · contact PI
Mechanism of aPL antibody-induced Pregnancy loss$332,030
R01 · FY2006 · AR · contact PI
ACR Basic Research Conference$40,000
R13 · FY2006 · AR · contact PI
Predictors of Pregnancy Outcome in SLE and APS$1,191,499
R01 · FY2005 · AR
Complement as a Mediator of Recurrent Miscarriages$355,000
R01 · FY2005 · AI
Mechanisms of aPL antibody-induced pregnancy loss$100,000
R55 · FY2005 · AR
ACR Basic Research Conference$50,000
R13 · FY2005 · AR
Predictors of Pregnancy Outcome in SLE and APS$1,167,785
R01 · FY2004 · AR
Complement as a Mediator of Recurrent Miscarriages$355,000
R01 · FY2004 · AI
RHEUMATOLOGY RESEARCH TRAINING PROGRAM$158,399
T32 · FY2004 · AR
Cartilage/Bone Biology: Pathogenesis-Joint Destruction$29,657
R13 · FY2004 · AR
Predictors of Pregnancy Outcome in SLE and APS$1,145,424
R01 · FY2003 · AR
RHEUMATOLOGY RESEARCH TRAINING PROGRAM$177,232
T32 · FY2003 · AR
Cartilage/Bone Biology: Pathogenesis-Joint Destruction$28,793
R13 · FY2003 · AR
RHEUMATOLOGY RESEARCH TRAINING PROGRAM$174,389
T32 · FY2002 · AR
Targets for New Therapeutics for SLE$20,000
U13 · FY2002 · AR
FC RECEPTOR FUNCTION IN NORMALS AND SLE$251,558
R01 · FY2001 · AR
RHEUMATOLOGY RESEARCH TRAINING PROGRAM$135,877
T32 · FY2001 · AR
Targets for New Therapeutics for SLE$20,000
U13 · FY2001 · AR
FC RECEPTOR FUNCTION IN NORMALS AND SLE$244,231
R01 · FY2000 · AR